at higher doses, dyspepsia, belching, and related symptoms become more prominent, a pattern consistent across T2DM and overweight/obese populations [108]
Current standard clinical treatments for DFU include surgical debridement, decompression therapy, vascular reconstruction, infection control, and dressing applications [6]
The translation gap between promising preclinical results and clinical validation is substantial, as evidenced by the limited number of engineered bacterial products that have progressed beyond early-phase trials
With this background, NTAPP-generated free radical species can be putative drivers modulating Wnt/-catenin signaling pathway in DP cells
Think of it as a checklist they go through